Fabrinet vs MakeMyTrip Ltd — how do they compare? Fabrinet trades at $486.28 (market cap $17.46B), while MakeMyTrip Ltd trades at $44.73 (market cap $4.09B). The key difference: Fabrinet is far larger — about 4.3× MakeMyTrip Ltd's market cap, and Fabrinet is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fabrinet for 30 Days and MakeMyTrip Ltd for 12 Days on average.
| FN | MMYT | |
|---|---|---|
Market Cap | $17.46B | $4.09B |
Volume | 1,199,886 | 1,828,010 |
Sector | Technology | Consumer Cyclical |
52-Week High | $746.47 | $92.25 |
52-Week Low | $361.94 | $36.30 |
Typical Hold Time | 30 Days | 12 Days |
Enterprise Value | $16.59B | $4.75B |
Signals from Pluang's Aura AI — not financial advice
Fabrinet (FN) trades at $487.33, down 2.14% on the day, amid a mixed technical backdrop with a bullish moving average signal but overbought RSI readings. Fundamentally, the company demonstrates strong profitability with a 10.19% net income margin and 21.33% ROE, supported by consecutive quarterly EPS beats. Recent news highlights surging AI data center demand driving revenue growth, though the stock faces pressure from high capital expenditures and customer concentration concerns.
The outlook remains positive given robust analyst sentiment (75% buy ratings) and a consensus price target of $769.50, implying significant upside. Key opportunities include capacity expansion to capture AI infrastructure growth, while risks involve margin compression from spending and reliance on a few hyperscaler customers. Earnings acceleration and market positioning support a constructive view, but volatility may persist near-term.
MakeMyTrip (MMYT) trades at $43.53, up 0.28% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported mixed quarterly earnings, with a Q1 2026 beat and Q4 2025 and Q2 2026 misses. Revenue grew to $978.34M in 2025, but net income margin compressed to 3.23% in 2026. Analyst consensus is strongly bullish with a $77.00 price target, though institutional selling has been noted recently.
The outlook is bifurcated: strong analyst support and a potential Indian listing offer upside, but declining profitability, high P/E ratio, and bearish technicals pose risks. Investors face volatility from operational execution and travel industry cyclicality against a backdrop of Wall Street optimism.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →